eMJA     The Medical Journal of Australia

Home | Issues | eMJA shop | My account | Classifieds | Contact | More... | Topics | Search   

Public Health

Evidence of primary transmission of multidrug-resistant tuberculosis in the Western Province of Papua New Guinea

Christopher M Gilpin, Graham Simpson, Stephen Vincent, Terry P O’Brien, Trevor A Knight, Maria Globan, Christopher Coulter and Anastasios Konstantinos
MJA 2008; 188 (3): 148-152
Abstract
Objective:

To review patient outcomes and the molecular epidemiology of multidrug-resistant tuberculosis (MDR-TB) strains isolated from patients living in the Western Province of Papua New Guinea (PNG) seeking treatment in Australia.

Design, setting and participants:

Review of all cases of MDR-TB among people living in the open border region between the Western Province of PNG and the Torres Strait Islands of Australia who presented to health clinics in the region between 2000 and 2006. All cases of suspected TB were bacteriologically confirmed at the time of presentation by the Mycobacterium Reference Laboratory in Brisbane.

Main outcome measures:

Drug resistance patterns; drug use and duration; molecular typing of TB strains; patient outcomes.

Results:

Between 2000 and 2006, 60 patients from the Western Province of PNG were diagnosed with TB, of which 15 had MDR-TB. Mortality was high, although no patient who was able to maintain access to supervised therapy died. All 15 MDR-TB isolates were Beijing-family strains showing the same unique mycobacterial interspersed repetitive unit (MIRU) profile, with the exception of a single strain that differed by a single repeat at one locus. Restriction fragment length polymorphism (RFLP) typing on 10 of these strains further differentiated them into two distinct clusters.

Conclusion:

Transmission of MDR-TB is occurring in the Western Province of PNG. Additional resources are urgently needed to interrupt the ongoing transmission of MDR-TB from the Western Province of PNG to the Torres Strait Islands. Good supervision and management of patient treatment, which includes ensuring a regular supply of second-line anti-TB drugs, are essential elements of TB control.

Login or register for free access to the full article

NB: If you are registered with the eMJA, your username is the email address you have provided.
AMA members can login using their AMA username and password.

If you don't have a login, click here to register for immediate free access

Username:

Password:

Password forgotten? Click here

Other articles have cited this article:

Home | Issues | eMJA shop | My account | Classifieds | More... | Contact | Topics | Search

The Medical Journal of Australia    eMJA  

©The Medical Journal of Australia 2008 www.mja.com.au PRINT ISSN: 0025-729X ONLINE ISSN: 1326-5377